NO20011667D0 - Behandling av dyspepsi - Google Patents

Behandling av dyspepsi

Info

Publication number
NO20011667D0
NO20011667D0 NO20011667A NO20011667A NO20011667D0 NO 20011667 D0 NO20011667 D0 NO 20011667D0 NO 20011667 A NO20011667 A NO 20011667A NO 20011667 A NO20011667 A NO 20011667A NO 20011667 D0 NO20011667 D0 NO 20011667D0
Authority
NO
Norway
Prior art keywords
dyspepsia
medicament
xanthophylls
prophylactic
individual
Prior art date
Application number
NO20011667A
Other languages
English (en)
Other versions
NO330158B1 (no
NO20011667L (no
Inventor
Aake Lignell
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Publication of NO20011667L publication Critical patent/NO20011667L/no
Publication of NO20011667D0 publication Critical patent/NO20011667D0/no
Publication of NO330158B1 publication Critical patent/NO330158B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20011667A 1998-10-16 2001-04-03 Anvendelse av xantofyller NO330158B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
PCT/EP1999/007551 WO2000023064A1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia

Publications (3)

Publication Number Publication Date
NO20011667L NO20011667L (no) 2001-04-03
NO20011667D0 true NO20011667D0 (no) 2001-04-03
NO330158B1 NO330158B1 (no) 2011-02-28

Family

ID=20412979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011667A NO330158B1 (no) 1998-10-16 2001-04-03 Anvendelse av xantofyller

Country Status (11)

Country Link
US (1) US6923967B1 (no)
EP (1) EP1121106B1 (no)
JP (1) JP2002527472A (no)
AT (1) ATE269065T1 (no)
AU (1) AU763995B2 (no)
CA (1) CA2346647C (no)
DE (1) DE69918152T2 (no)
ES (1) ES2222732T3 (no)
NO (1) NO330158B1 (no)
SE (1) SE524337C2 (no)
WO (1) WO2000023064A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058064A1 (ja) 2003-12-19 2005-06-30 Menicon Co., Ltd. アスタキサンチン配合ペット用食物
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
EP3040069A4 (en) * 2013-06-27 2017-04-12 The Doshisha Intestinal flora improving composition containing astaxanthin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57105145A (en) * 1980-12-23 1982-06-30 Koichi Tanaka Feed additive
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IL110139A0 (en) 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
AU4715796A (en) * 1995-02-03 1996-08-21 Basf Aktiengesellschaft Use of carotinoids for preparing medicaments for treating dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE522246C2 (sv) * 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Also Published As

Publication number Publication date
DE69918152D1 (de) 2004-07-22
EP1121106A1 (en) 2001-08-08
ATE269065T1 (de) 2004-07-15
CA2346647A1 (en) 2000-04-27
SE524337C2 (sv) 2004-07-27
SE9803541D0 (sv) 1998-10-16
NO330158B1 (no) 2011-02-28
DE69918152T2 (de) 2005-07-07
NO20011667L (no) 2001-04-03
AU763995B2 (en) 2003-08-07
AU6201699A (en) 2000-05-08
WO2000023064A1 (en) 2000-04-27
JP2002527472A (ja) 2002-08-27
ES2222732T3 (es) 2005-02-01
SE9803541L (sv) 2000-04-17
EP1121106B1 (en) 2004-06-16
US6923967B1 (en) 2005-08-02
CA2346647C (en) 2003-03-11

Similar Documents

Publication Publication Date Title
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
Levine et al. Retinoids as well as tumour promoters enhance deacylation of cellular lipids and prostaglandin production in MDCK cells
CN1827766B (zh) 体外细胞的培养方法
Chakdar et al. Algal pigments for human health and cosmeceuticals
RU2409290C2 (ru) Композиции, пригодные для лечения кожных признаков старения
ATE243030T1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
US6258855B1 (en) Method of retarding and ameliorating carpal tunnel syndrome
DE69026496D1 (de) Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
BR0013309A (pt) Fragmento de ácido nucléico isolado, complemento, gene quimérico, planta ou célula hospedeira transformada, planta transformada, planta ou célula hospedeira, sementes, óleo método de alteração do nìvel de ácidos graxos em uma planta ou célula hospedeira, método de produção de óleo se sementes contendo ácidos graxos, método para a produção de enzimas modificadoras de ácidos graxos, método para isolar fragmentos de ácidos nucléicos e seus subfragmentos funcionalmente equivalentes, alimentos animal e método para aprimorar a qualidade de carcaça de um animal
ATE355832T1 (de) Pharmazeutisch aktive karotenoide
AU6649996A (en) Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
SE9803541L (sv) Behandling av dyspepsi
JPH0657659B2 (ja) 消化管にて種々のレベルで消化促進剤として作用する酵素組成物
SE9704590L (sv) Sätt att öka produktionen av och förbättra kvaliteten hos sperma
Rodriguez-Lopez et al. Plasma-glucose and plasma-insulin in normal and alloxanized rats treated with Chlorella
Fuller et al. Aortic connective tissue changes in miniature pigs fed a lipid-rich diet
CA2405479A1 (en) Method of inhibiting the expression of inflammatory cytokines and chemokines
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
CN1393222B (zh) 一种溶解在油脂中的甾醇化合物的组合物的新用途
JP5063040B2 (ja) 血管新生阻害剤
HUP9802314A2 (hu) Zeaxantin tiszta 3R-3'R sztereoizomerje makuláris degeneráció emberben való kezelésére
KR19990017766A (ko) 로스마린산으로 노화 스톱
JPH0987620A (ja) 子葉処理体及びその製造方法
KR20200066154A (ko) 홍해삼 추출물을 함유하는 조성물의 제조방법
WO1994003075A3 (en) Morphogen-enriched dietary composition

Legal Events

Date Code Title Description
MK1K Patent expired